++
+++
Essentials of Diagnosis
++
Pale, anesthetic macular—or nodular and erythematous—skin lesions
Superficial nerve thickening with resultant anesthesia
History of residence in endemic area in childhood
Acid-fast bacilli in skin lesions or nasal scrapings, or characteristic histologic nerve changes
+++
General Considerations
++
A chronic infectious disease caused by the acid-fast rod Mycobacterium leprae
The mode of transmission probably is respiratory droplets and involves prolonged exposure in childhood
The disease is divided into two distinct types: lepromatous and tuberculoid
The lepromatous type occurs in persons with defective cellular immunity
In the tuberculoid type, cellular immunity is intact and the course is more benign
++
The disease is endemic in tropical and subtropical Asia, Africa, Central and South America, and the Pacific regions
++
The onset is insidious
The lesions involve the cooler body tissues: skin, superficial nerves, nose, pharynx, larynx, eyes, and testicles
Skin lesions may occur as
Pale, anesthetic macular lesions 1–10 cm in diameter
Discrete erythematous, infiltrated nodules 1–5 cm in diameter
Diffuse skin infiltration
Neurologic disturbances are caused by nerve infiltration and thickening, with resultant anesthesia, and motor abnormalities
Bilateral ulnar neuropathy is highly suggestive
+++
LEPROMATOUS TYPE (MULTIBACILLARY LEPROSY)
++
+++
TUBERCULOID TYPE (PAUCIBACILLARY LEPROSY)
++
The course is more benign and less progressive, with macular skin lesions and severe asymmetric nerve involvement of sudden onset
Intermediate ("borderline") cases are frequent. Eye involvement (keratitis and iridocyclitis), nasal ulcers, epistaxis, anemia, and lymphadenopathy may occur
+++
Differential Diagnosis
++
++
M leprae does not grow in artificial media but does grow in the footpads of armadillos
The lepromatous type: abundant acid-fast bacilli in the skin lesions and a negative lepromin skin test
The tuberculoid type: few bacilli present in the lesions and a positive lepromin skin test
+++
Diagnostic Procedures
++
++
Combination therapy is recommended for treatment of all types of leprosy
For borderline and lepromatous cases (ie, multibacillary disease), the World Health Organization recommends
A triple oral drug regimen of rifampin, 600 mg once a month; dapsone, 100 mg/day; and clofazimine, 300 mg ...